Altre lingue Yuyu Pharma, Inc.

Azioni

A000220

KR7000220004

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 03/05/2024			Variaz. 5gg	Var. 1 gen.
4.705 ^KRW	+0,97%		+1,51%	-10,89%

20/03	Yuyu Pharma, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Yuyu Pharma, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Yuyu Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Yuyu Pharma to attend 'CPHI Worldwide 2023'	18/10/23
Yuyu Pharma, Inc. announced that it has received KRW 24.5 billion in funding from a group of investors	22/05/23
Yuyu Pharma, Inc. announced that it expects to receive KRW 24.5 billion in funding from a group of investors	18/05/23
Yuyu Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Yuyu Pharma Unveils the Results of Its Mechanism of Action and Head-To- Head Studies for Its Dry Eye Treatment Peptide	27/04/23
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Tranche Update on Yuyu Pharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.	24/10/22
Tranche Update on Yuyu Pharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.	24/10/22
Yuyu Pharma, Inc.'s Equity Buyback announced on September 19, 2022, has closed with 304,878 shares, representing 1.83% for KRW 1,785.24 million.	20/10/22
Yuyu Pharma, Inc. announces an Equity Buyback for 304,878 shares.	19/09/22
Yuyu Pharma, Inc. authorizes a Buyback Plan.	19/09/22
Yuyu Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
Yuyu Pharma Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating YP-P10 Ophthalmic Solution for the Treatment of Dry Eye Disease	20/07/22
Yuyu Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22
Yuyu Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	23/03/22
Yuyu Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Bourse Zurich: le SMI termine dans le vert, un peu sous les 12'200 points	04/08/21
Bourse Zurich: le SMI toujours en hausse à l'approche de la mi-journée	04/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Yuyu Pharma, Inc.

Azioni

A000220

KR7000220004

Altre lingue

Filtri